Skip to main content
Toggle navigation
Login
Search
Home
Full Schedule
Home
Full Schedule
All Days
Fri, Mar 31
Sat, Apr 1
Thu, Apr 20
Fri, Apr 21
Fri, May 19
Sat, May 20
Thu, Jun 15
Fri, Jun 16
Fri, Jul 21
Sat, Jul 22
Thu, Aug 17
Fri, Aug 18
Thu, Sep 14
Fri, Sep 15
Full Schedule
Type here to filter the list
Friday, March 31, 2023
1:15 PM – 2:00 PM
.
Welcome and Session I: 2023 Updates in IBD Management
Speaker:
Millie D. Long, MD, MPH, FACG
– University of North Carolina at Chapel Hill
Speaker:
Florian Rieder, MD
– Cleveland Clinic
1:15 PM – 2:00 PM
.
Welcome and Session I: 2023 Updates in IBD Management
Speaker:
Millie D. Long, MD, MPH, FACG
– University of North Carolina at Chapel Hill
Speaker:
Florian Rieder, MD
– Cleveland Clinic
1:15 PM – 1:35 PM
.
Update on the Management of UC
Speaker:
Millie D. Long, MD, MPH, FACG
– University of North Carolina at Chapel Hill
1:35 PM – 1:55 PM
.
Update on the Management of CD
Speaker:
Florian Rieder, MD
– Cleveland Clinic
1:55 PM – 2:00 PM
.
Q&A Panel
2:00 PM – 3:00 PM
.
Non-CME Innovation Theater
2:00 PM – 3:00 PM
.
Non-CME Innovation Theater
3:00 PM – 3:45 PM
.
Session II: Optimizing Existing Therapies in the Management of IBD
Speaker:
Jessica R. Allegretti, MD,MPH, FACG, AGAF
– Brigham and Women's Hospital, Harvard Medical School
3:00 PM – 3:45 PM
.
Session II: Optimizing Existing Therapies in the Management of IBD
Speaker:
Jessica R. Allegretti, MD,MPH, FACG, AGAF
– Brigham and Women's Hospital, Harvard Medical School
3:00 PM – 3:30 PM
.
Optimizing Existing Therapies in the Management of IBD
Speaker:
Jessica R. Allegretti, MD,MPH, FACG, AGAF
– Brigham and Women's Hospital, Harvard Medical School
3:30 PM – 3:45 PM
.
Q&A Panel
3:45 PM – 4:45 PM
.
Non-CME Innovation Theater
3:45 PM – 4:45 PM
.
Non-CME Innovation Theater
5:00 PM – 5:45 PM
.
Session III: Stricturing Crohn's Disease
Speaker:
Florian Rieder, MD
– Cleveland Clinic
5:00 PM – 5:45 PM
.
Session III: Stricturing Crohn's Disease
Speaker:
Florian Rieder, MD
– Cleveland Clinic
5:00 PM – 5:30 PM
.
Stricturing Crohn's Disease
Speaker:
Florian Rieder, MD
– Cleveland Clinic
5:30 PM – 5:45 PM
.
Q&A Panel
Saturday, April 1, 2023
6:45 AM – 7:45 AM
.
Non-CME Innovation Theater
6:45 AM – 7:45 AM
.
Non-CME Innovation Theater
8:00 AM – 8:15 AM
.
Session IV
8:00 AM – 8:15 AM
.
Welcome
8:15 AM – 9:00 AM
.
Session IV: Special Situations in UC
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG
– University of Maryland School of Medicine
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
8:15 AM – 9:00 AM
.
Session IV: Special Situations in UC
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG
– University of Maryland School of Medicine
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
8:15 AM – 8:30 AM
.
Management of Hospitalized UC Patient
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG
– University of Maryland School of Medicine
8:30 AM – 8:45 AM
.
Dysplasia in IBD: Best Practices
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
8:45 AM – 9:00 AM
.
Panel Discussion and Q&A
Panelist:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
Panelist:
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his)
– Cleveland Clinic
Moderator:
Millie D. Long, MD, MPH, FACG
– University of North Carolina at Chapel Hill
Moderator:
Florian Rieder, MD
– Cleveland Clinic
9:00 AM – 9:45 AM
.
Session V: Optimized Care for Patients With IBD: The Potential Benefits of Interleukin Inhibitors
Speaker:
Millie D. Long, MD, MPH, FACG
– University of North Carolina at Chapel Hill
9:00 AM – 9:45 AM
.
Session V: Optimized Care for Patients With IBD: The Potential Benefits of Interleukin Inhibitors
Speaker:
Millie D. Long, MD, MPH, FACG
– University of North Carolina at Chapel Hill
9:00 AM – 9:30 AM
.
Optimized Care for Patients With IBD: The Potential Benefits of Interleukin Inhibitors
Speaker:
Millie D. Long, MD, MPH, FACG
– University of North Carolina at Chapel Hill
9:30 AM – 9:45 AM
.
Q&A Panel
9:45 AM – 10:30 AM
.
Session VI: Special Situations in IBD
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
Speaker:
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his)
– Cleveland Clinic
9:45 AM – 10:30 AM
.
Session VI: Special Situations in IBD
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
Speaker:
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his)
– Cleveland Clinic
9:45 AM – 10:00 AM
.
Pregnancy in IBD
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
10:00 AM – 10:15 AM
.
Management of Perianal Crohn's disease
Speaker:
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his)
– Cleveland Clinic
10:15 AM – 10:30 AM
.
Q&A Panel
11:00 AM – 12:00 PM
.
Lunch and Exhibit Hall Break
11:00 AM – 12:00 PM
.
Lunch and Exhibit Hall Break
12:15 PM – 1:00 PM
.
Session VII: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
Speaker:
Florian Rieder, MD
– Cleveland Clinic
12:15 PM – 1:00 PM
.
Session VII: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
Speaker:
Florian Rieder, MD
– Cleveland Clinic
12:15 PM – 12:30 PM
.
JAK Inhibitors: Efficacy and Safety
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
12:30 PM – 12:45 PM
.
Role of Anti-TNF and Anti-Integrin in IBD
Speaker:
Florian Rieder, MD
– Cleveland Clinic
12:45 PM – 1:00 PM
.
Q&A Panel
1:00 PM – 1:45 PM
.
Session VIII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG
– University of Maryland School of Medicine
1:00 PM – 1:45 PM
.
Session VIII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG
– University of Maryland School of Medicine
1:00 PM – 1:30 PM
.
Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG
– University of Maryland School of Medicine
1:30 PM – 1:45 PM
.
Q&A Panel
2:00 PM – 3:00 PM
.
Non-CME Innovation Theater
2:00 PM – 3:00 PM
.
Non-CME Innovation Theater
3:15 PM – 4:00 PM
.
Session IX: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
3:15 PM – 4:00 PM
.
Session IX: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
3:15 PM – 3:45 PM
.
Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
3:45 PM – 4:00 PM
.
Q&A Panel
4:00 PM – 4:45 PM
.
Session X: Putting your knowledge to the test: Challenging IBD cases
4:00 PM – 4:45 PM
.
Session X: Putting your knowledge to the test: Challenging IBD cases
4:00 PM – 4:45 PM
.
Case Panel
